GW Pharmaceuticals in Cannabis R&D Deal with Japan’s Otsuka Pharmaceutical Co., Ltd.

July 9, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, July 9 (Reuters) - Britain's GW Pharmaceuticals Plc said on Monday it had signed a deal with Japan's Otsuka Pharmaceutical Co to research and develop drugs based on cannabis as treatments for cancer and central nervous system disorders.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe